WuXi AppTec

In News

China pharma projects disrupted by Sino-US tensions - Reuters

Reuters - Jun 17, 2025

WuXi AppTec's Capital Allocation Strategy: Boosting Value Through Share Repurchases and Talent Incentives - AInvest

AInvest - Jul 08, 2025

WuXi AppTec's Massive $3.5B Share Strategy: Buyback Program and Employee Stock Plan Details Revealed - Stock Titan

Stock Titan - Jul 08, 2025

WuXi AppTec Provides Updates on Q2 Share Repurchase, Acquisition Activities - MarketScreener

MarketScreener - Jul 08, 2025

WuXi AppTec sells UK-US units, but annual results show foreign contracts continue despite China tensions - Pharmaceutical Technology

Pharmaceutical Technology - Mar 27, 2025

WuXi AppTec offers rosy 2025 guidance despite threat of US-China trade tensions - Fierce Pharma

Fierce Pharma - Mar 18, 2025

Press Release: WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities - 富途牛牛

富途牛牛 - Jul 08, 2025

WuXi AppTec Receives MSCI ESG AAA Leader Rating - The Manila Times

The Manila Times - Jul 07, 2025

WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity - PR Newswire

PR Newswire - Jun 26, 2025

WuXi AppTec sells US medical device testing business to NAMSA - Fierce Biotech

Fierce Biotech - Jan 17, 2025

Chinese biotech giant sees strong US revenue despite trade tensions - South China Morning Post

South China Morning Post - Apr 29, 2025

WuXi AppTec sells off cell and gene therapy operations in US, UK - FirstWord Pharma

FirstWord Pharma - Dec 26, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.